DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,395 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,395,861 | -77.4% | 29,810 | -78.1% | 0.11% | -83.0% |
| Q2 2023 | $32,712,960 | +250.3% | 136,304 | +267.9% | 0.62% | +202.4% |
| Q1 2023 | $9,337,578 | +341.8% | 37,048 | +365.3% | 0.21% | +488.6% |
| Q4 2022 | $2,113,539 | -86.4% | 7,963 | -86.8% | 0.04% | -85.2% |
| Q3 2022 | $15,535,000 | +4.4% | 60,145 | +2.4% | 0.24% | -28.0% |
| Q2 2022 | $14,874,000 | +82.8% | 58,740 | +111.7% | 0.33% | +203.7% |
| Q1 2022 | $8,138,000 | +1051.1% | 27,745 | +1094.9% | 0.11% | +881.8% |
| Q3 2021 | $707,000 | -92.2% | 2,322 | -93.1% | 0.01% | -91.3% |
| Q2 2021 | $9,021,000 | -26.2% | 33,614 | -38.1% | 0.13% | -54.0% |
| Q1 2021 | $12,219,000 | -49.0% | 54,289 | -51.2% | 0.28% | -89.2% |
| Q3 2020 | $23,979,000 | -46.2% | 111,357 | -55.8% | 2.56% | -32.5% |
| Q2 2020 | $44,558,000 | +789.6% | 251,981 | +596.3% | 3.79% | +325.4% |
| Q1 2020 | $5,009,000 | -67.6% | 36,190 | -64.1% | 0.89% | -45.6% |
| Q4 2019 | $15,463,000 | -20.1% | 100,751 | -24.8% | 1.64% | -24.8% |
| Q3 2019 | $19,353,000 | -11.0% | 133,993 | -11.9% | 2.18% | -9.9% |
| Q2 2019 | $21,735,000 | +186.5% | 152,080 | +164.6% | 2.42% | +201.9% |
| Q1 2019 | $7,587,000 | +71.7% | 57,465 | +41.3% | 0.80% | +80.8% |
| Q3 2018 | $4,420,000 | +37.6% | 40,675 | -1.5% | 0.44% | -7.5% |
| Q4 2016 | $3,213,000 | +628.6% | 41,280 | +637.1% | 0.48% | +122.8% |
| Q2 2014 | $441,000 | -95.0% | 5,600 | -95.2% | 0.22% | -95.6% |
| Q1 2014 | $8,801,000 | +2.2% | 117,350 | +5.2% | 4.85% | +46.8% |
| Q4 2013 | $8,608,000 | +16.9% | 111,500 | +5.0% | 3.30% | -19.7% |
| Q3 2013 | $7,362,000 | +306.7% | 106,200 | +271.3% | 4.11% | +268.9% |
| Q2 2013 | $1,810,000 | – | 28,600 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |